Lymphoma
Lymphoma
Advertisement
Cecilia BrownNews | February 7, 2024
Psychosocial care and support are critical parts of cancer care, according to the International Psycho-Oncology Society.
Read More
Cecilia BrownHematology & Blood Cancer | January 15, 2024
Researchers developed and piloted a novel phone-delivered positive psychology intervention called PATH.
Dustin SamplesConferences | October 17, 2023
Accelerated approvals will no longer be granted based on overall response rates in single-arm trials.
Dustin SamplesLymphoma | October 17, 2023
A case series demonstrated the effectiveness of a novel trio for pediatric plasmacytic PTLD.
Leah LawrenceTreatment | October 17, 2023
A recently approved TIW schedule provides new option for patients with ALL or LBL receiving asparaginase.
Dustin SamplesHematology & Blood Cancer | October 17, 2023
Interprofessional team-based care is the standard for patients undergoing HSCT. But who belongs on the team?
Patrick DalyLymphoma | October 17, 2023
Robert E. Brown, MD, and collaborating researchers from the University of Texas Health Science Center at Houston McGovern ...
Patrick DalyLymphoma | October 17, 2023
A study published in the Journal of Cancer Research and Clinical Oncology discussed outcomes of anti-CD20-based combination ...
Patrick DalyLymphoma | October 17, 2023
Data on diffuse large B-cell lymphoma (DLBCL) from the OncoCollect Lymphoma group registry were recently published in ...
Patrick DalyLymphoma | October 17, 2023
A study published in European Radiology examined the prognostic efficacy of automatic segmentation of diffuse large B-cell ...
Patrick DalyLymphoma | October 17, 2023
According to a study published in the International Journal of Radiation Oncology, Biology, Physics, approximately 50% of ...
Patrick DalyLymphoma | October 17, 2023
According to an article in Translational Cancer Research, data on the clinical outcomes of patients with primary diffuse ...
Patrick DalyLymphoma | October 17, 2023
Recent first-line randomized controlled trials (RCTs) for patients with diffuse large B-cell lymphoma (DLCBL) have ...
Patrick DalyLymphoma | October 17, 2023
The prevalence of diffuse large b-cell lymphoma (DLBCL) necessitates a thorough understanding of its gene expression profile; ...
Patrick DalyLymphoma | October 17, 2023
Researchers, led by Wenyujing Zhou, aimed to determine the benefits and risks of anti-CD19 chimeric antigen receptor (CAR) ...
Patrick DalyLymphoma | October 17, 2023
Italian researchers, led by Mario Petrini, postulated that subcutaneous (SC) rituximab could be advantageous compared to ...
Patrick DalyLymphoma | November 16, 2023
Limited treatment options are typically available for patients over 65 years old with these lymphomas.
Patrick DalyLymphoma | October 17, 2023
Ferroptosis is an iron-dependent programmed cell death caused by lipid peroxidation; however, according to a study published ...
Patrick DalyLymphoma | October 17, 2023
Noting that diffuse large B-cell lymphoma (DLBCL) generally occurs in elderly individuals, researchers Cancan Luo, Han Lie, ...
Patrick DalyLymphoma | October 17, 2023
Citing an unmet clinical need in the identification and understanding of prognostic biomarkers for aggressive B-cell ...
Advertisement
Advertisement
Advertisement